Trials / Sponsors / Xinhong Wu, PhD
Xinhong Wu, PhD
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for HR+/HER2- Breast Cancer | Phase 2 | 2024-12-20 |
| Completed | Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer Breast Cancer Stage III | N/A | 2019-02-27 |